1. Home
  2. NX vs ABCL Comparison

NX vs ABCL Comparison

Compare NX & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NX
  • ABCL
  • Stock Information
  • Founded
  • NX 1927
  • ABCL 2012
  • Country
  • NX United States
  • ABCL Canada
  • Employees
  • NX N/A
  • ABCL N/A
  • Industry
  • NX Metal Fabrications
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NX Industrials
  • ABCL Health Care
  • Exchange
  • NX Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • NX 824.7M
  • ABCL 772.9M
  • IPO Year
  • NX N/A
  • ABCL 2020
  • Fundamental
  • Price
  • NX $18.47
  • ABCL $2.05
  • Analyst Decision
  • NX Strong Buy
  • ABCL Buy
  • Analyst Count
  • NX 1
  • ABCL 3
  • Target Price
  • NX $38.00
  • ABCL $7.50
  • AVG Volume (30 Days)
  • NX 367.0K
  • ABCL 4.5M
  • Earning Date
  • NX 06-05-2025
  • ABCL 05-08-2025
  • Dividend Yield
  • NX 1.69%
  • ABCL N/A
  • EPS Growth
  • NX N/A
  • ABCL N/A
  • EPS
  • NX 0.29
  • ABCL N/A
  • Revenue
  • NX $1,438,751,000.00
  • ABCL $23,114,000.00
  • Revenue This Year
  • NX $48.92
  • ABCL N/A
  • Revenue Next Year
  • NX $3.10
  • ABCL $36.62
  • P/E Ratio
  • NX $65.27
  • ABCL N/A
  • Revenue Growth
  • NX 29.87
  • ABCL N/A
  • 52 Week Low
  • NX $15.30
  • ABCL $1.89
  • 52 Week High
  • NX $35.26
  • ABCL $4.34
  • Technical
  • Relative Strength Index (RSI)
  • NX 57.73
  • ABCL 41.69
  • Support Level
  • NX $16.13
  • ABCL $1.95
  • Resistance Level
  • NX $19.27
  • ABCL $2.18
  • Average True Range (ATR)
  • NX 0.67
  • ABCL 0.14
  • MACD
  • NX 0.34
  • ABCL -0.03
  • Stochastic Oscillator
  • NX 81.58
  • ABCL 26.81

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its three operating segments are North American Fenestration being the key revenue driver, European Fenestration, and North American Cabinet Components. Geographically, it derives a majority of revenue from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: